Companies · Other Health Care
Southlake · Other Health Care
Diligence memoA one-page analyst read on Low T Centers Inc — recommendation, valuation, rhythm, risks.→Low T Centers Inc looks under-valued against its niche peers and is active on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Low T Centers Inc is one of 5376 Other Health Care companies tracked from Southlake. By capital raised it ranks among the largest (ahead of 91% of sector peers), and in the upper tier by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.
Round size and date are reported; the stage label is inferred from round size (latest is Series B — a $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 91% of sector peers (real $). Modeled value above 84% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series B | $40.0M | — | $222.2M | $142.0M | 90% |
| Series B | $40.0M | — | $222.2M | $142.0M | 90% |
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| David Grinbergs | — | — | — |
| David Grinburgs | — | — | — |
| David Moraine | — | — | — |
| Michael Sisk | — | — | — |
Low T Centers Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Laplace Interventional, Inc. | Other Health Care | Series B | $42.0M | $114.8M | same sector · same stage |
| True Medicine Inc. | Other Health Care | Series B | $42.7M | $175.7M | same sector · same stage |
| Nuelle, Inc. | Other Health Care | Series B | $36.6M | $156.2M | same sector · same stage |
| Luminopia, Inc. | Other Health Care | Series B | $36.5M | $142.0M | same sector · same stage |
| Myra Vision, Inc. | Other Health Care | Series B | $36.0M | $108.7M | same sector · same stage |
| STX Healthcare Management Services, Inc. | Other Health Care | Series B | $35.7M | $128.2M | same sector · same stage |
| Getlabs, Inc. | Other Health Care | Series B | $35.7M | $161.7M | same sector · same stage |
| Pionyr Immunotherapeutics, Inc. | Other Health Care | Series B | $45.0M | $155.1M | same sector · same stage |
See where Low T Centers Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Low T Centers Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.